Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes
Open accessAbstract
Statins, the widely prescribed cholesterol-lowering drugs for the treatment of cardiovascular disease, cause adverse skeletal muscle side effects ranging from fatigue to fatal rhabdomyolysis. The purpose of this study was to determine the effects of simvastatin on mitochondrial respiration, oxidative stress, and cell death in differentiated primary human skeletal muscle cells (i.e., myotubes). Simvastatin induced a dose-dependent decrease in viability of proliferating and differentiating primary human muscle precursor cells, and a similar dose-dependent effect was noted in differentiated myoblasts and myotubes. Additionally, there were decreases in myotube number and size following 48 h of simvastatin treatment (5 μM). In permeabilized myotubes, maximal ADP-stimulated oxygen consumption, supported by palmitoylcarnitine+malate (PCM, complex I and II substrates) and glutamate+malate (GM, complex I substrates), was 32-37% lower (P<0.05) in simvastatin-treated (5 μM) vs control myotubes, providing evidence of impaired respiration at complex I. Mitochondrial superoxide and hydrogen peroxide generation were significantly greater in the simvastatin-treated human skeletal myotube cultures compared to control. In addition, simvastatin markedly increased protein levels of Bax (proapoptotic, +53%) and Bcl-2 (antiapoptotic, +100%, P<0.05), mitochondrial PTP opening (+44%, P<0.05), and TUNEL-positive nuclei in human skeletal myotubes, demonstrating up-regulation of mitochondrial-mediated myonuclear apoptotic mechanisms. These data demonstrate that simvastatin induces myotube atrophy and cell loss associated with impaired ADP-stimulated maximal mitochondrial respiratory capacity, mitochondrial oxidative stress, and apoptosis in primary human skeletal myotubes, suggesting that mitochondrial dysfunction may underlie human statin-induced myopathy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Kwak et al. reported impaired ADP-stimulated respiration in primary human skeletal myotubes after 48 h of simvastatin treatment, accompanied by increased mitochondrial oxidative stress.
“Recently Kwak et al. (40) reported impaired ADP-stimulated respiration in primary human skeletal myotubes after 48 h of simvastatin treatment, and this was accompanied by increased mitochondrial oxidative stress (hydrogen peroxide emission).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [40]
Reduced antioxidant capacity combined with known elevated ROS production makes it plausible that increased apoptosis contributes to muscle pain in statin-treated patients.
“Our findings of significantly reduced antioxidant capacity in combination with the known (3,40) elevated ROS production in the simvastatin-treated patients make it plausible that increased apoptosis could contribute to muscle pain in patients treated with statins.”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [40]
Increased Ca2+ load in the mitochondrial matrix is linked to increased ROS production and permeability transition pore opening, leading to apoptosis.
“In turn, an increased Ca 2ϩ load in the mitochondrial matrix has been linked to increased ROS production and increased permeability transition pore opening, leading to apoptosis (40,45).”
From Simvastatin Effects on Skeletal Muscle (2013) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 7,397 · see citing works
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
Cannon, C. P., Braunwald, E., McCabe, C. H., Rader, D. J., Rouleau, J. L., Belder, R., Joyal, S. V., Hill, K. A., Pfeffer, M. A., & Skene, A. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040583 · Cited by 4,938 · see citing works
Wang, H., & Joseph, J. A. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00107-0 · Cited by 2,355 · see citing works
Thompson, P. D., Clarkson, P., & Karas, R. H. (2003) · JAMA · doi:10.1001/jama.289.13.1681 · Cited by 1,463 · see citing works
Anderson, E. J., Lustig, M. E., Boyle, K. E., Woodlief, T. L., Kane, D. A., Lin, C.-T., Price, J. W., Kang, L., Rabinovitch, P. S., Szeto, H. H., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37048 · Cited by 1,253 · see citing works
Self-citationSafety of Statins: Focus on Clinical Pharmacokinetics and Drug Interactions
Bellosta, S., Paoletti, R., & Corsini, A. (2004) · Circulation · doi:10.1161/01.cir.0000131519.15067.1f · Cited by 578 · see citing works
Statin-associated myopathy with normal creatine kinase levels
Phillips, P. S., Haas, R. H., Bannykh, S., Hathaway, S., Gray, N. L., Kimura, B. J., Vladutiu, G. D., England, J. D. F., & and the Scripps Mercy Clinical Research Center* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00009 · Cited by 565 · see citing works
The Role of Coenzyme Q10 in Statin-Associated Myopathy
Marcoff, L., & Thompson, P. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.02.049 · Cited by 537 · see citing works
Suction applied to a muscle biopsy maximizes sample size
Evans, W. J., Phinney, S. D., & Young, V. R. (1982) · Medicine & Science in Sports & Exercise · doi:10.1249/00005768-198201000-00018 · Cited by 520 · see citing works
Guijarro, C., Blanco‐Colio, L. M., Ortego, M., Alonso, C., Ortíz, A., Plaza, J. J. G., Dı́az-Jullien, C., Hernández, G., & Egido, J. (1998) · Circulation Research · doi:10.1161/01.res.83.5.490 · Cited by 390 · see citing works
WANAGAT, J., CAO, Z., PATHARE, P., & AIKEN, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.00-0320com · Cited by 378 · see citing works
Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle
Lawler, J. M. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00186-2 · Cited by 370 · see citing works
Mechanisms of disuse muscle atrophy: role of oxidative stress
Powers, S. K., Kavazis, A. N., & DeRuisseau, K. C. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00469.2004 · Cited by 368 · see citing works
Regulation of the Permeability Transition Pore in Skeletal Muscle Mitochondria
Fontaine, E. M., Eriksson, O., Ichas, F., & Bernardi, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.20.12662 · Cited by 347 · see citing works
Simple quantitative detection of mitochondrial superoxide production in live cells
Mukhopadhyay, P., Rajesh, M., Kashiwaya, Y., Haskó, G., & Pacher, P. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.04.106 · Cited by 328 · see citing works
High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial
PAIVA, H., THELEN, K., COSTER, R., SMET, J., PAEPE, B., MATTILA, K., LAAKSO, J., LEHTIMAKI, T., VONBERGMANN, K., & LUTJOHANN, D. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2005.03.006 · Cited by 308 · see citing works
Toxicity of statins on rat skeletal muscle mitochondria
Kaufmann, P., Török, M., Zahno, A., Waldhauser, K. M., Brecht, K., & Krähenbühl, S. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6235-z · Cited by 263 · see citing works
Detaille, D., Guigas, B., Chauvin, C., Batandier, C., Fontaine, E., Wiernsperger, N., & Leverve, X. (2005) · Diabetes · doi:10.2337/diabetes.54.7.2179 · Cited by 263 · cited 1× · see citing works
“Additionally, we observed impaired complex I-linked maximal ADP-stimulated respiration, increased mitochondrial oxidative stress, and increased pro-apoptotic Bax protein levels, all of which are indicative of increased susceptibility to PTP opening[41, 50] [50, 51] [48].”
BackgroundDE PINIEUX, G., CHARIOT, P., AMMI‐SAÏD, M., LOUARN, F., LEJONC, J. L., ASTIER, A., JACOTOT, B., & GHERARDI, R. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.04178.x · Cited by 262 · see citing works
Statin-induced apoptosis and skeletal myopathy
Dirks, A. J., & Jones, K. M. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00226.2006 · Cited by 240 · see citing works
Mitochondria and the Bcl-2 family proteins in apoptosis signaling pathways
Antonsson, B. E. (2003) · Molecular and Cellular Biochemistry · doi:10.1023/b:mcbi.0000009865.70898.36 · Cited by 232 · see citing works
Sinzinger, H. F., & O’Grady, J. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2003.02044.x · Cited by 223 · see citing works
Oxidative stress and the mitochondrial theory of aging in human skeletal muscle
Parise, G., Jan, K. J., Douglas, M. J., Phillips, S. M., & Tarnopolsky, M. A. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.002 · Cited by 223 · see citing works
Statin-Induced Muscle Necrosis in the Rat: Distribution, Development, and Fibre Selectivity
Westwood, F. R., Bigley, A. L., Randall, K., Marsden, A. M., & Scott, R. C. (2005) · Toxicologic Pathology · doi:10.1080/01926230590908213 · Cited by 212 · see citing works
Lipid-Lowering Drugs and Risk of Myopathy: A Population-Based Follow-Up Study
Gaist, D., Rodríguez, L. A. G., Huerta, C., Hallas, J., & Sindrup, S. H. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00017 · Cited by 210 · see citing works
Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy
Silva, M. J., Matthews, M. L., Jarvis, C. I., Nolan, N. M., Belliveau, P., Malloy, M., & Gandhi, P. J. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.02.008 · Cited by 207 · see citing works
Statins: a new insight into their mechanisms of action and consequent pleiotropic effects.
Jasińska-Stroschein, M., Owczarek, J., & Orszulak–Michalak, D. (2007) · PubMed · Cited by 192 · see citing works
New insights into mechanisms of statin-associated myotoxicity
Sirvent, P., Mercier, J. G., & Lacampagne, A. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.010 · Cited by 190 · see citing works
Lovastatin increases exercise-induced skeletal muscle injury
Thompson, P. D., Zmuda, J. M., Domalik, L. J., Zimet, R., Staggers, J. E., & Guyton, J. R. (1997) · Metabolism · doi:10.1016/s0026-0495(97)90218-3 · Cited by 177 · see citing works
Simvastatin triggers mitochondria-induced Ca2+ signaling alteration in skeletal muscle
Sirvent, P., Mercier, J., Vassort, G., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.070 · Cited by 154 · see citing works
Response of the ubiquitin-proteasome pathway to changes in muscle activity
Reid, M. B. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00545.2004 · Cited by 154 · see citing works
Rhabdomyolysis with HMG‐CoA reductase inhibitors and gemfibrozil combination therapy
Chang, J. T., Staffa, J. A., Parks, M. A., & Green, L. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.977 · Cited by 152 · see citing works
Johnson, T. E. (2004) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.04.010 · Cited by 146 · see citing works
Yokota, T., Kinugawa, S., Hirabayashi, K., Matsushima, S., Inoue, N., Ohta, Y., Hamaguchi, S., Sobirin, M. A., Ono, T., Suga, T., et al. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00267.2009 · Cited by 139 · see citing works
Apoptotic signaling induced by H2O2-mediated oxidative stress in differentiated C2C12 myotubes
Siu, P. M., Wang, Y., & Alway, S. E. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.01.014 · Cited by 131 · see citing works
Differential metabolic effects of distinct statins
Koh, K. K., Sakuma, I., & Quon, M. J. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.10.036 · Cited by 130 · see citing works
Simvastatin induces impairment in skeletal muscle while heart is protected
Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Raynaud, E., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.108 · Cited by 116 · see citing works
Molecular basis of statin-associated myopathy
Vaklavas, C., Chatzizisis, Y. S., Ziakas, A., Zamboulis, C., & Giannoglou, G. D. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.05.021 · Cited by 114 · see citing works
Sacher, J., Weigl, L. G., Werner, M., Szegedi, C., & HOHENEGGER, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086462 · Cited by 103 · see citing works
Myotoxicity associated with lipid-lowering drugs
Baer, A. N., & Wortmann, R. L. (2006) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e328010c559 · Cited by 93 · see citing works
Statin myopathy: Incidence, risk factors, and pathophysiology
Sewright, K. A., Clarkson, P. M., & Thompson, P. D. (2007) · Current Atherosclerosis Reports · doi:10.1007/s11883-007-0050-3 · Cited by 90 · see citing works
Odagiri, K., Katoh, H., Kawashima, H., Tanaka, T. L., Ohtani, H., Saotome, M., Urushida, T., Satoh, H., & Hayashi, H. (2009) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2008.12.022 · Cited by 83 · see citing works
Statins induce calcium-dependent mitochondrial permeability transition
Velho, J. A., Okanobo, H., Degasperi, G. R., Matsumoto, M. Y., Alberici, L. C., Cosso, R. G., Oliveira, H. C. F., & Vercesi, A. E. (2005) · Toxicology · doi:10.1016/j.tox.2005.11.007 · Cited by 77 · see citing works
Effects of ubiquinone (coenzyme Q10) on myopathy in statin users
Schaars, C. F., & Stalenhoef, A. F. H. (2008) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283168ecd · Cited by 74 · see citing works
Pierno, S., Didonna, M. P., Cippone, V., Luca, A. D., Pisoni, M., Frigeri, A., Nicchia, G. P., Svelto, M., Chiesa, G., Sirtori, C. R., et al. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706917 · Cited by 65 · see citing works
Demyanets, S., Kaun, C., Pfaffenberger, S., Hohensinner, P. J., Rega‐Kaun, G., Pammer, J., Maurer, G., Huber, K., & Wojta, J. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.016 · Cited by 57 · see citing works
van Vliet, A. K., Nègre‐Aminou, P., van Thiel, G. C. F., Bolhuis, P. A., & Cohen, L. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(96)00467-4 · Cited by 38 · see citing works
Preventive effects of bicarbonate on cerivastatin-induced apoptosis
Kobayashi, M., Kaido, F., Kagawa, T., Itagaki, S., Hirano, T., & Iseki, K. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.04.010 · Cited by 26 · see citing works
Statins Effect on Smooth Muscle Cell Proliferation
Bellosta, S., Arnaboldi, L., Gerosa, L., Canavesi, M., Parente, R., Baetta, R., Paoletti, R., & Corsini, A. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-869591 · Cited by 25 · see citing works
Veerkamp, J. H., Smit, J. W. A., Benders, A. A. G. M., & Oosterhof, A. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00122-0 · Cited by 19 · see citing works
Arnaboldi, L., Guzzetta, M., Pazzucconi, F., Radaelli, G., Paoletti, R., Sirtori, C. R., & Corsini, A. (2007) · Pharmacological Research · doi:10.1016/j.phrs.2007.09.012 · Cited by 7 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al‐Rasadi, K., Aronow, W. S., Athyros, V. G., Djuric, D. M., Владиславович, Е. М., et al. (2015) · Archives of Medical Science · doi:10.5114/aoms.2015.49807 · Cited by 381 · see citing works
Effects of statins on mitochondrial pathways
Mollazadeh, H., Tavana, E., Fanni, G., Bo, S., Banach, M., Pirro, M., von Haehling, S., Jamialahmadi, T., & Sahebkar, A. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12654 · Cited by 259 · see citing works
Simvastatin Impairs Exercise Training Adaptations
Mikus, C. R., Boyle, L. J., Borengasser, S. J., Oberlin, D. J., Naples, S. P., Fletcher, J. A., Meers, G. M.-E., Ruebel, M. L., Laughlin, M. H., Dellsperger, K. C., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.074 · Cited by 244 · see citing works
Makrecka‐Kuka, M., Krumschnabel, G., & Gnaiger, E. (2015) · Biomolecules · doi:10.3390/biom5031319 · Cited by 237 · see citing works
Turner, R. M., & Pirmohamed, M. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm9010022 · Cited by 201 · see citing works
Mitophagy Is Required for Acute Cardioprotection by Simvastatin
Andres, A. M., Hernandez, G., Lee, P., Huang, C., Ratliff, E. P., Sin, J., Thornton, C. A., Damasco, M. V., & Gottlieb, R. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5416 · Cited by 189 · see citing works
Statins: Adverse reactions, oxidative stress and metabolic interactions
Liu, A., Wu, Q., Guo, J., Arés, I., Rodríguez, J.-L., Martínez‐Larrañaga, M., Yuan, Z., Anadón, A., Wang, X., & Martínez, M. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.004 · Cited by 168 · see citing works
Simvastatin Effects on Skeletal Muscle
Larsen, S., Stride, N., Hey-Mogensen, M., Hansen, C. N., Bang, L. E., Bundgaard, H., Nielsen, L. B., Helge, J. W., & Dela, F. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.09.036 · Cited by 165 · see citing works
Banach, M., Rizzo, M., Toth, P. P., Farnier, M., Davidson, M. H., Al-Rasadi, K., Aronow, W. S., Athyros, V., Djuric, D. M., Ezhov, M. V., et al. (2015) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.1039980 · Cited by 162 · see citing works
Myotoxicity of statins: Mechanism of action
du Souich, P., Roederer, G. O., & Dufour, R. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.029 · Cited by 162 · see citing works
Mechanisms of statin-associated skeletal muscle-associated symptoms
Bouitbir, J., Sanvee, G. M., Panajatovic, M. V., Singh, F., & Krähenbühl, S. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.03.010 · Cited by 146 · see citing works
The role of mitochondria in statin‐induced myopathy
Apostolopoulou, M., Corsini, A., & Roden, M. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12461 · Cited by 142 · see citing works
Gouni‐Berthold, I., Berthold, H. K., Huh, J. Y., Berman, R., Spenrath, N., Krone, W., & Mantzoros, C. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072858 · Cited by 133 · see citing works
Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans
Merritt, E. K., Stec, M. J., Thalacker-Mercer, A., Windham, S. T., Cross, J. M., Shelley, D. P., Craig Tuggle, S., Kosek, D. J., Kim, J.-S., & Bamman, M. M. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00019.2013 · Cited by 127 · see citing works
Self-citationBurguillos, M. Á., Magnusson, C., Antfolk, M., Lenshof, A., Augustsson, P., Hansson, M. J., Elmér, E., Lilja, H. G., Brundin, P., Laurell, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064233 · Cited by 122 · see citing works
Mechanisms and assessment of statin‐related muscular adverse effects
Moßhammer, D., Schaeffeler, E., Schwab, M. G., & Mörike, K. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12360 · Cited by 110 · see citing works
The AKT/mTOR signaling pathway plays a key role in statin-induced myotoxicity
Bonifacio, A., Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.04.010 · Cited by 93 · see citing works
Bouitbir, J., Singh, F., Charles, A., Schlagowski, A.-I., Bonifacio, A., Echaniz‐Laguna, A., Gény, B., Krähenbühl, S., & Zoll, J. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6190 · Cited by 95 · see citing works
Muscle mitochondrial metabolism and calcium signaling impairment in patients treated with statins
Sirvent, P., Fabre, O., Bordenave, S., Hillaire-Buys, D., Raynaud De Mauverger, E., Lacampagne, A., & Mercier, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.01.008 · Cited by 90 · see citing works
Statins, Bcl-2, and Apoptosis: Cell Death or Cell Protection?
Wood, W. G., Igbavboa, U., Muller, W. E., & Eckert, G. P. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8496-5 · Cited by 89 · see citing works
Muntean, D. M., Thompson, P. D., Catapano, A. L., Stasiolek, M., Fabis, J., Muntner, P., Serban, M.-C., & Banach, M. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2016.09.001 · Cited by 82 · see citing works
Mitochondrial Respiratory Capacity and Content Are Normal in Young Insulin-Resistant Obese Humans
Fisher-Wellman, K. H., Weber, T. M., Cathey, B. L., Brophy, P. M., Gilliam, L. A. A., Kane, C. L., Maples, J. M., Gavin, T. P., Houmard, J. A., & Neufer, P. D. (2014) · Diabetes · doi:10.2337/db13-0940 · Cited by 82 · see citing works
Self-citationDastkhoon, M., Ghaedi, M., Asfaram, A., Arabi, M., Ostovan, A., & Goudarzi, A. (2016) · Ultrasonics Sonochemistry · doi:10.1016/j.ultsonch.2016.10.030 · Cited by 79 · see citing works
Urbano, F., Bugliani, M., Filippello, A., Scamporrino, A., Mauro, S. D., Pino, A. D., Scicali, R., Noto, D., Rabuazzo, A. M., Averna, M. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-11070-x · Cited by 78 · see citing works
Risk of diabetes in patients treated with HMG-CoA reductase inhibitors
Cho, Y., Choe, E.-Y., Lee, Y., Seo, J. W., Choi, Y., Yun, Y., Wang, H. J., Ahn, C. W., Soo, B., Lee, H. C., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.008 · Cited by 73 · see citing works
Bonifacio, A., Mullen, P. J., Mityko, I. S., Navegantes, L. C. C., Bouitbir, J., & Krähenbühl, S. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1378-4 · Cited by 61 · see citing works
Marcheggiani, F., Cirilli, I., Orlando, P., Silvestri, S., Vogelsang, A., Knott, A., Blatt, T., Weise, J. M., & Tiano, L. (2019) · Aging · doi:10.18632/aging.101926 · Cited by 53 · see citing works
Egom, E. E. A., & Hafeez, H. (2016) · Advances in clinical chemistry · doi:10.1016/bs.acc.2015.10.005 · Cited by 54 · see citing works
Li, W., Liang, X., Zeng, Z., Yu, K., Zhan, S., Su, Q., Yan, Y., Mansai, H., Qiao, W., Yang, Q., et al. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.06.029 · Cited by 50 · see citing works
Guardia, P. G. L., Alberici, L. C., Ravagnani, F. G., Catharino, R. R., & Vercesi, A. E. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00103 · Cited by 46 · see citing works
Mechanisms of simvastatin myotoxicity: The role of autophagy flux inhibition
Emami, A., Shojaei, S., Rosa, S. C. D. S., Aghaei, M., Samiei, E., Vosoughi, A. R., Kalantari, F., Kawalec, P., Thliveris, J. A., Sharma, P. K., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172616 · Cited by 42 · see citing works
Goldstein, M. R., & Mascitelli, L. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0368-x · Cited by 41 · see citing works
Mallinson, J. E., Constantin‐Teodosiu, D., Glaves, P. D., Martin, E. A., Davies, W. J., Westwood, F. R., Sidaway, J. E., & Greenhaff, P. L. (2012) · The Journal of Physiology · doi:10.1113/jphysiol.2012.238022 · Cited by 40 · see citing works
Southern, W. M., Nichenko, A. S., Shill, D. D., Spencer, C. C., Jenkins, N. T., McCully, K. K., & Call, J. A. (2017) · PLoS ONE · doi:10.1371/journal.pone.0172551 · Cited by 39 · see citing works
Neuropsychological and physiological correlates of fatigue following traumatic brain injury
Zgaljardic, D. J., Durham, W. J., Mossberg, K. A., Foreman, J., Joshipura, K. D., Masel, B. E., Urban, R. J., & Sheffield‐Moore, M. (2014) · Brain Injury · doi:10.3109/02699052.2014.884242 · Cited by 38 · see citing works
Jiménez-Santos, M. A., Juárez‐Rojop, I. E., Tovilla‐Zárate, C. A., Espinosa-García, M. T., Juárez-Oropeza, M. A., Ramón-Frías, T., Bermudez‐Ocaña, D. Y., & Díaz-Zagoya, J. C. (2014) · Lipids in Health and Disease · doi:10.1186/1476-511x-13-22 · Cited by 37 · see citing works
Costa, R. A. P. E., Fernandes, M. P., de Souza-Pinto, N. C., & Vercesi, A. E. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.01.001 · Cited by 35 · see citing works
Busanello, E. N. B., Marques, A. C. S., Lander, N. M., de Oliveira, D. N., Catharino, R. R., Oliveira, H. C. F., & Vercesi, A. E. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00185 · Cited by 34 · see citing works
The Impact of Exercise on Statin-Associated Skeletal Muscle Myopathy
Chung, H. R., Vakil, M., Munroe, M., Parikh, A., Meador, B. M., Wu, P. T., Jeong, J., Woods, J. A., Wilund, K. R., & Boppart, M. D. (2016) · PLoS ONE · doi:10.1371/journal.pone.0168065 · Cited by 33 · see citing works
Barrat, E., Zaïr, Y., Sirvent, P., Chauveau, P., Maudet, C., Housez, B., Derbord, E., Lescuyer, J.-F., Bard, J.-M., Cazaubiel, M., et al. (2013) · European Journal of Nutrition · doi:10.1007/s00394-012-0486-2 · Cited by 31 · see citing works
The Influence of Statins on the Aerobic Metabolism of Endothelial Cells
Broniarek, I., Dominiak, K., Gałgański, Ł., & Jarmuszkiewicz, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041485 · Cited by 29 · see citing works
Huang, X., Liang, N. N., Fuming, Z., Lin, W., & Ma, W. (2024) · Antioxidants · doi:10.3390/antiox13060679 · Cited by 31 · see citing works
Simvastatin Inhibits Glucose Metabolism and Legumain Activity in Human Myotubes
Smith, R. L., Solberg, R., Jacobsen, L. L., Voreland, A. L., Rustan, A. C., Thoresen, G. H., & Johansen, H. T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085721 · Cited by 29 · see citing works
Exercise-Pharmacology Interactions: Metformin, Statins, and Healthspan
Miller, B. F., & Thyfault, J. P. (2020) · Physiology · doi:10.1152/physiol.00013.2020 · Cited by 29 · see citing works
Jaśkiewicz, A., Pająk, B., Litwiniuk, A., Urbańska, K., & Orzechowski, A. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/6463807 · Cited by 28 · see citing works
Use of antidepressants and statins and short-term risk of new-onset diabetes among high risk adults
Bhattacharya, R., Ajmera, M., Bhattacharjee, S., & Sambamoorthi, U. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.016 · Cited by 27 · see citing works
RYAN, T. E., Torres, M. J., Lin, C., Clark, A. H., Brophy, P. M., Smith, C. A. S., Smith, C. D., Morris, E. M., Thyfault, J. P., & Neufer, P. D. (2024) · JCI Insight · doi:10.1172/jci.insight.174125 · Cited by 26 · see citing works
Self-citationRen, L., Xuan, L., Han, F., Zhang, J., Gong, L., Lv, Y., Zhang, W., Yang, S. T., Xu, B., Yan, Y., et al. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115076 · Cited by 25 · see citing works
PGC-1β modulates statin-associated myotoxicity in mice
Singh, F., Zoll, J., Duthaler, U., Charles, A., Panajatovic, M. V., LAVERNY, G., McWilliams, T. G., METZGER, D., Gény, B., Krähenbühl, S., et al. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2369-7 · Cited by 23 · see citing works
Statin therapy, myopathy and exercise--a case report
Semple, S. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-40 · Cited by 22 · see citing works
Asping, M., Stride, N. O., Søgaard, D., Dohlmann, T. L., Helge, J. W., Dela, F., & Larsen, S. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2224-4 · Cited by 22 · see citing works
Kwak, H., Woodlief, T., Green, T. D., Cox, J. H., Hickner, R. C., Neufer, P. D., & Cortright, R. N. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16071157 · Cited by 22 · see citing works
Self-citationSkeletal muscle ultrastructure and function in statin-tolerant individuals
Rengo, J. L., Callahan, D. M., Savage, P. D., Ades, P. A., & Toth, M. J. (2015) · Muscle & Nerve · doi:10.1002/mus.24722 · Cited by 21 · see citing works
Cho, Y., Lee, M. J., Choe, E. Y., Jung, C. H., Joo, D. J., Kim, M. S., Soo, B., Park, J., & Kang, E. S. (2014) · Liver Transplantation · doi:10.1002/lt.23831 · Cited by 20 · see citing works
The Role of Mitochondria in Statin-Induced Myopathy
Bell, G. M., Thoma, A., Hargreaves, I. P., & Lightfoot, A. P. (2024) · Drug Safety · doi:10.1007/s40264-024-01413-9 · Cited by 21 · see citing works
Involvement of Monocarboxylate Transporter 4 Expression in Statin-Induced Cytotoxicity
Kikutani, Y., Kobayashi, M., Konishi, T., Sasaki, S., Narumi, K., Furugen, A., Takahashi, N., & Iseki, K. (2016) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2016.01.014 · Cited by 19 · see citing works
Zheng, P., Zhang, Q., Ma, W., Hu, R., Gu, Y., Bian, Z., Yang, D., Chen, X., & Wu, H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.176085 · Cited by 18 · see citing works
Marques, A. C. S., Busanello, E. N. B., de Oliveira, D. N., Catharino, R. R., Oliveira, H. C. F., & Vercesi, A. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00685 · Cited by 18 · see citing works
PGC‐1α plays a pivotal role in simvastatin‐induced exercise impairment in mice
Panajatovic, M. V., Singh, F., Roos, N. J., Duthaler, U., Handschin, C., Krähenbühl, S., & Bouitbir, J. (2019) · Acta Physiologica · doi:10.1111/apha.13402 · Cited by 17 · see citing works
Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise
Kwak, H. (2014) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2014.4.2.71 · Cited by 16 · see citing works
Self-citationAssis, L. H. D. P., Dorighello, G. G., Rentz, T., de Souza, J. C., Vercesi, A. E., & Oliveira, H. C. F. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.839428 · Cited by 15 · see citing works
A short-term statin treatment changes the contractile properties of fast-twitch skeletal muscles
Boulanger‐Piette, A., Dufresne, S. S., & Frenette, J. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1306-2 · Cited by 15 · see citing works
Insulin prevents and reverts simvastatin-induced toxicity in C2C12 skeletal muscle cells
Sanvee, G. M., Bouitbir, J., & Krähenbühl, S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43938-5 · Cited by 15 · see citing works
Peric, D., Barragán, I., Giraud-Triboult, K., Egesipe, A.-L., Meyniel‐Schicklin, L., Cousin, C., Lotteau, V., Petit, V., Touhami, J., Battini, J., et al. (2015) · Stem Cells · doi:10.1002/stem.2107 · Cited by 14 · see citing works
Jaśkiewicz, A., Pająk, B., Łabieniec-Watała, M., Palma, C. D., & Orzechowski, A. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050694 · Cited by 13 · see citing works
Xue, Y., Tao, L., Wu, S., Wang, G., Lu, Q., Li, J., Liao, L., Tang, J.-F., & Ji, K. (2017) · BMC Cardiovascular Disorders · doi:10.1186/s12872-017-0560-z · Cited by 12 · see citing works
Irwin, J. C., Fenning, A. S., Ryan, K., & Vella, R. K. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.09.040 · Cited by 12 · see citing works
Simvastatin profoundly impairs energy metabolism in primary human muscle cells
Mäkinen, S., Datta, N., Nguyen, Y. H., Kyrylenko, P., Laakso, M., & Koistinen, H. A. (2020) · Endocrine Connections · doi:10.1530/ec-20-0444 · Cited by 12 · see citing works
Modulation of Phospholipid Bilayer Properties by Simvastatin
Teo, R. D., & Tieleman, D. P. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03359 · Cited by 12 · see citing works
Dayel, F. F. B., Alfirevic, A., & Chadwick, A. E. (2023) · Biomedicines · doi:10.3390/biomedicines11051485 · Cited by 11 · see citing works
Mahmoud, A. R., Kamel, E. O., Ahmed, M. A., Ahmed, E. A., & Abd‐Elhamid, T. H. (2019) · Cells Tissues Organs · doi:10.1159/000507048 · Cited by 11 · see citing works
Effect of L-carnitine on the skeletal muscle contractility in simvastatin-induced myopathy in rats
Ghalwash, M., Elmasry, A., & El-Adeeb, N. (2018) · Journal of Basic and Clinical Physiology and Pharmacology · doi:10.1515/jbcpp-2017-0156 · Cited by 10 · see citing works
Lorza‐Gil, E., García‐Arévalo, M., Favero‐Santos, B. C., Gomes‐Marcondes, M. C. C., & Oliveira, H. C. F. (2019) · Journal of Translational Medicine · doi:10.1186/s12967-019-2045-6 · Cited by 9 · see citing works
Cholesterol Management in Neurology: Time for Revised Strategies?
Andronie-Cioară, F. L., Jurcău, A., Jurcău, M. C., Nistor-Cseppento, C. D., & Simion, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12121981 · Cited by 9 · see citing works
Al-Shalchi, R. F., & MOHAMMAD, F. K. (2024) · Cureus · doi:10.7759/cureus.51433 · Cited by 7 · see citing works
Otrocka‐Domagała, I., Paździor‐Czapula, K., & Maślanka, T. (2018) · BioMed Research International · doi:10.1155/2018/7617312 · Cited by 7 · see citing works
Dynamic urine proteome changes in a rat model of simvastatin-induced skeletal muscle injury
Wei, J., Huan, Y., Heng, Z., Zhao, C., Jia, L., Yu, Y., & Gao, Y. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2021.104477 · Cited by 7 · see citing works
Murad, H. A. S. (2016) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b1500065 · Cited by 6 · see citing works
d’Hose, D., Mignion, L., Hamelin, L., Sonveaux, P., Jordan, B. F., & Gallez, B. (2022) · Biomolecules · doi:10.3390/biom12101418 · Cited by 6 · see citing works
Effect of Statins on Superoxide Dismutase Level: A Systematic Review
Daliri, M., Simental‐Mendía, L. E., Jamialahmadi, T., Kesharwani, P., Reiner, Ž., & Sahebkar, A. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230831145809 · Cited by 6 · see citing works
Corsetti, G., Pasini, E., Ferrari-Vivaldi, M., Romano, C., Bonomini, F., Tasca, G., Dioguardi, F. S., Rezzani, R., & Assanelli, D. (2012) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201202500423 · Cited by 6 · see citing works
Seo, D. Y., Heo, J., No, M., Yoo, S.-Z., Ko, J. R., Park, D., Kang, J., Kim, C., Jung, S., Han, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072292 · Cited by 6 · see citing works
Self-citationStatins, toxicity, and their adverse effects via oxidative imbalance
Anadón, A., Arés, I., Martínez-Larrañaga, M. R., & Martínez, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819092-0.00026-1 · Cited by 5 · see citing works
Somers, T., Siddiqi, S., Janssen, M. C. M., Morshuis, W. J., Maas, R. G. C., Buikema, J. W., van den Broek, P. H. H., Schirris, T. J. J., & Rüssel, F. G. M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117492 · Cited by 5 · see citing works
Jianfei, L., Wang, M., Ma, C.-L., Chen, B., Zhang, J., & Wang, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.10.005 · Cited by 5 · see citing works
Saied, S., Prokopidis, K., Adenaya, A., Isanejad, M., & Sankaranarayanan, R. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1293537 · Cited by 4 · see citing works
Interaction of atorvastatin with the human glial transporter SLC16A1.
Sasaki, S., Futagi, Y., Ideno, M., Kobayashi, M., Narumi, K., Furugen, A., & Iseki, K. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.033 · Cited by 6 · see citing works
Assessment of bee venom therapy in animal model of statin-induced myopathy
Kader, A. A., Azmy, R. M., Maher, E. A., Sayed, B. B. E., Khalil, A. S., Ghalwash, M., & Mahmoud, M. M. (2019) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-019-0120-9 · Cited by 4 · see citing works
Busanello, E. N. B., Marques, A. C. S., Lorza‐Gil, E., Oliveira, H. C. F., & Vercesi, A. E. (2018) · InTech eBooks · doi:10.5772/intechopen.71610 · Cited by 3 · see citing works
Statins Stimulate Hepatic Glucose Production via the miR-183/96/182 ClusterPreprint
Marquart, T. J., Allen, R. M., Chen, M. R., Dorn, G. W., Matkovich, S. J., & Baldán, Á. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/726695 · Cited by 3 · see citing works
Al-Shalchi, R. F., & MOHAMMAD, F. K. (2024) · Applied In Vitro Toxicology · doi:10.1089/aivt.2024.0032 · Cited by 2 · see citing works
Chronic Hepatitis B: A Critical Discussion
Long, J., Wang, M., Chen, B., Zhang, J., & Wang, B. (2017) · Future Virology · doi:10.2217/fvl-2016-0094 · Cited by 2 · see citing works
Salehinezhad, F., Eshraghi, H., Kadivar, A., Shirian, S., Asghari, A., Aali, E., & Davoodian, N. (2019) · Kafkas Universitesi Veteriner Fakultesi Dergisi · doi:10.9775/kvfd.2019.21726 · Cited by 1 · see citing works
The effect of simvastatin induced neurotoxicity on mitochondrial function in human neuronal cells
Millichap, L. E., Turton, N., Alomosh, R., Heaton, R. A., Bateman, A., Al‐Shanti, N., Lightfoot, A. P., Damiani, E., Marcheggiani, F., Orlando, P., et al. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2471807 · Cited by 1 · see citing works
Sjúrðarson, T., Larsen, S., Jensen, S. B. K., Bejder, J., Rasmussen, J., Borg, S. Á., Kristiansen, J., Meinhardsson, J. M., Olsen, H. W., Ellingsgaard, H., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-101425 · Cited by 1 · see citing works
Importance of Plasma Membrane Nanodomains in Skeletal Muscle Regeneration
Pająk, B., & Orzechowski, A. (2015) · InTech eBooks · doi:10.5772/60615
The Impact of Physical Activity on Statin-Associated Skeletal Muscle Myopathy
Chung, H. R., Wu, P.-T., Fitschen, P. J., Kistler, B. M., Park, H. W., Jeong, J. H., Wilund, K. R., Woods, J., & Boppart, M. D. (2015) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000477291.98365.c0
impair regenerative capacity in aging humans Heightened muscle inflammation susceptibility may
Kim, J., Bamman, M. M., Cross, J. M., Shelley, D., Tuggle, S. C., Kosek, D. J., Merritt, E. K., Stec, M. J., Thalacker‐Mercer, A. E., Williams, J. Y., et al. (2015)
Self-citationRegulation of legumain in human cells
Smith, R. L. (2014) · NORA - Norwegian Open Research Archives
Er cysteinproteaser involvert i statinindusert myotoksisitet
Voreland, A. L. (2013) · NORA - Norwegian Open Research Archives
- Authors
- Kwak, H.-B., Thalacker-Mercer, A., Anderson, E. J., Lin, C.-T., Kane, D. A., Lee, N.-S., Cortright, R. N., Bamman, M. M., & Neufer, P. D.
- Affiliations
- East Carolina University (US)
- University of Alabama at Birmingham (US)
- Corresponding author
- Neufer, P. Darrell
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2012-01
- Volume
- 52
- Issue
- 1
- Pages
- 198-207
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC3313473
- OpenAlex
- W1985595789
- Cited by
- 114
- References
- 52
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 13 · 2018: 10 · 2017: 10 · 2016: 11 · 2015: 11 · 2014: 12 · 2013: 12 · 2012: 7
- FWCI
- 4.03
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (R01AG017896)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK073488, R01DK075880, R01DK074825)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Coenzyme Q10 studies and effects
- Keywords
- simvastatin, statin-induced myopathy, skeletal muscle, myotubes, mitochondrial respiration, complex I, mitochondrial oxidative stress, superoxide, hydrogen peroxide, apoptosis, Bax, Bcl-2, mitochondrial permeability transition, myotube atrophy, rhabdomyolysis
- MeSH terms
- Adenosine Diphosphate, Anticholesteremic Agents, Cell Differentiation, Dose-Response Relationship, Drug, Humans, Hydrogen Peroxide, Mitochondria, Muscular Diseases, Oxygen Consumption, Superoxides, Signal Transduction, Gene Expression, Apoptosis, Oxidative Stress, Muscle Fibers, Skeletal, Cell Respiration, Respiratory System Agents, Proto-Oncogene Proteins c-bcl-2, Simvastatin, Myoblasts, Electron Transport Complex I, Primary Cell Culture
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review